Emily K Osterweil, Shih-Chieh Chuang, Alexander A Chubykin, Michael Sidorov, Riccardo Bianchi, Robert K S Wong, Mark F Bear. Neuron 2013
Times Cited: 155
Times Cited: 155
Times Cited
Times Co-cited
Similarity
Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.
Emily K Osterweil, Dilja D Krueger, Kimberly Reinhold, Mark F Bear. J Neurosci 2010
Emily K Osterweil, Dilja D Krueger, Kimberly Reinhold, Mark F Bear. J Neurosci 2010
44
The mGluR theory of fragile X mental retardation.
Mark F Bear, Kimberly M Huber, Stephen T Warren. Trends Neurosci 2004
Mark F Bear, Kimberly M Huber, Stephen T Warren. Trends Neurosci 2004
38
Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.
Aubin Michalon, Michael Sidorov, Theresa M Ballard, Laurence Ozmen, Will Spooren, Joseph G Wettstein, Georg Jaeschke, Mark F Bear, Lothar Lindemann. Neuron 2012
Aubin Michalon, Michael Sidorov, Theresa M Ballard, Laurence Ozmen, Will Spooren, Joseph G Wettstein, Georg Jaeschke, Mark F Bear, Lothar Lindemann. Neuron 2012
34
Correction of fragile X syndrome in mice.
Gül Dölen, Emily Osterweil, B S Shankaranarayana Rao, Gordon B Smith, Benjamin D Auerbach, Sumantra Chattarji, Mark F Bear. Neuron 2007
Gül Dölen, Emily Osterweil, B S Shankaranarayana Rao, Gordon B Smith, Benjamin D Auerbach, Sumantra Chattarji, Mark F Bear. Neuron 2007
34
Altered synaptic plasticity in a mouse model of fragile X mental retardation.
Kimberly M Huber, Sean M Gallagher, Stephen T Warren, Mark F Bear. Proc Natl Acad Sci U S A 2002
Kimberly M Huber, Sean M Gallagher, Stephen T Warren, Mark F Bear. Proc Natl Acad Sci U S A 2002
32
Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.
Christina Henderson, Lasani Wijetunge, Mika Nakamoto Kinoshita, Matthew Shumway, Rebecca S Hammond, Friso R Postma, Christopher Brynczka, Roger Rush, Alexia Thomas, Richard Paylor,[...]. Sci Transl Med 2012
Christina Henderson, Lasani Wijetunge, Mika Nakamoto Kinoshita, Matthew Shumway, Rebecca S Hammond, Friso R Postma, Christopher Brynczka, Roger Rush, Alexia Thomas, Richard Paylor,[...]. Sci Transl Med 2012
30
FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.
Jennifer C Darnell, Sarah J Van Driesche, Chaolin Zhang, Ka Ying Sharon Hung, Aldo Mele, Claire E Fraser, Elizabeth F Stone, Cynthia Chen, John J Fak, Sung Wook Chi,[...]. Cell 2011
Jennifer C Darnell, Sarah J Van Driesche, Chaolin Zhang, Ka Ying Sharon Hung, Aldo Mele, Claire E Fraser, Elizabeth F Stone, Cynthia Chen, John J Fak, Sung Wook Chi,[...]. Cell 2011
30
Metformin ameliorates core deficits in a mouse model of fragile X syndrome.
Ilse Gantois, Arkady Khoutorsky, Jelena Popic, Argel Aguilar-Valles, Erika Freemantle, Ruifeng Cao, Vijendra Sharma, Tine Pooters, Anmol Nagpal, Agnieszka Skalecka,[...]. Nat Med 2017
Ilse Gantois, Arkady Khoutorsky, Jelena Popic, Argel Aguilar-Valles, Erika Freemantle, Ruifeng Cao, Vijendra Sharma, Tine Pooters, Anmol Nagpal, Agnieszka Skalecka,[...]. Nat Med 2017
29
Effect of lovastatin on behavior in children and adults with fragile X syndrome: an open-label study.
Artuela Çaku, David Pellerin, Paméla Bouvier, Emilie Riou, Francois Corbin. Am J Med Genet A 2014
Artuela Çaku, David Pellerin, Paméla Bouvier, Emilie Riou, Francois Corbin. Am J Med Genet A 2014
62
Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.
Aditi Bhattacharya, Hanoch Kaphzan, Amanda C Alvarez-Dieppa, Jaclyn P Murphy, Philippe Pierre, Eric Klann. Neuron 2012
Aditi Bhattacharya, Hanoch Kaphzan, Amanda C Alvarez-Dieppa, Jaclyn P Murphy, Philippe Pierre, Eric Klann. Neuron 2012
27
Dysregulation of mTOR signaling in fragile X syndrome.
Ali Sharma, Charles A Hoeffer, Yukihiro Takayasu, Takahiro Miyawaki, Sean M McBride, Eric Klann, R Suzanne Zukin. J Neurosci 2010
Ali Sharma, Charles A Hoeffer, Yukihiro Takayasu, Takahiro Miyawaki, Sean M McBride, Eric Klann, R Suzanne Zukin. J Neurosci 2010
22
Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse.
Mei Qin, Julia Kang, Thomas V Burlin, Chunhui Jiang, Carolyn Beebe Smith. J Neurosci 2005
Mei Qin, Julia Kang, Thomas V Burlin, Chunhui Jiang, Carolyn Beebe Smith. J Neurosci 2005
22
A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome.
Mary Jacena S Leigh, Danh V Nguyen, Yi Mu, Tri I Winarni, Andrea Schneider, Tasleem Chechi, Jonathan Polussa, Paul Doucet, Flora Tassone, Susan M Rivera,[...]. J Dev Behav Pediatr 2013
Mary Jacena S Leigh, Danh V Nguyen, Yi Mu, Tri I Winarni, Andrea Schneider, Tasleem Chechi, Jonathan Polussa, Paul Doucet, Flora Tassone, Susan M Rivera,[...]. J Dev Behav Pediatr 2013
21
Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.
T V Bilousova, L Dansie, M Ngo, J Aye, J R Charles, D W Ethell, I M Ethell. J Med Genet 2009
T V Bilousova, L Dansie, M Ngo, J Aye, J R Charles, D W Ethell, I M Ethell. J Med Genet 2009
21
Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.
Elizabeth M Berry-Kravis, David Hessl, Barbara Rathmell, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Yi Mu, Danh V Nguyen, Joseph Gonzalez-Heydrich, Paul P Wang,[...]. Sci Transl Med 2012
Elizabeth M Berry-Kravis, David Hessl, Barbara Rathmell, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Yi Mu, Danh V Nguyen, Joseph Gonzalez-Heydrich, Paul P Wang,[...]. Sci Transl Med 2012
20
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.
Elizabeth Berry-Kravis, Vincent Des Portes, Randi Hagerman, Sébastien Jacquemont, Perrine Charles, Jeannie Visootsak, Marc Brinkman, Karin Rerat, Barbara Koumaras, Liansheng Zhu,[...]. Sci Transl Med 2016
Elizabeth Berry-Kravis, Vincent Des Portes, Randi Hagerman, Sébastien Jacquemont, Perrine Charles, Jeannie Visootsak, Marc Brinkman, Karin Rerat, Barbara Koumaras, Liansheng Zhu,[...]. Sci Transl Med 2016
20
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.
Q J Yan, M Rammal, M Tranfaglia, R P Bauchwitz. Neuropharmacology 2005
Q J Yan, M Rammal, M Tranfaglia, R P Bauchwitz. Neuropharmacology 2005
19
Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome.
Christina Gross, Chia-Wei Chang, Seth M Kelly, Aditi Bhattacharya, Sean M J McBride, Scott W Danielson, Michael Q Jiang, Chi Bun Chan, Keqiang Ye, Jay R Gibson,[...]. Cell Rep 2015
Christina Gross, Chia-Wei Chang, Seth M Kelly, Aditi Bhattacharya, Sean M J McBride, Scott W Danielson, Michael Q Jiang, Chi Bun Chan, Keqiang Ye, Jay R Gibson,[...]. Cell Rep 2015
27
Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.
Harpreet Sidhu, Lorraine E Dansie, Peter W Hickmott, Douglas W Ethell, Iryna M Ethell. J Neurosci 2014
Harpreet Sidhu, Lorraine E Dansie, Peter W Hickmott, Douglas W Ethell, Iryna M Ethell. J Neurosci 2014
18
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.
A J Verkerk, M Pieretti, J S Sutcliffe, Y H Fu, D P Kuhl, A Pizzuti, O Reiner, S Richards, M F Victoria, F P Zhang. Cell 1991
A J Verkerk, M Pieretti, J S Sutcliffe, Y H Fu, D P Kuhl, A Pizzuti, O Reiner, S Richards, M F Victoria, F P Zhang. Cell 1991
18
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
Elizabeth M Berry-Kravis, Lothar Lindemann, Aia E Jønch, George Apostol, Mark F Bear, Randall L Carpenter, Jacqueline N Crawley, Aurore Curie, Vincent Des Portes, Farah Hossain,[...]. Nat Rev Drug Discov 2018
Elizabeth M Berry-Kravis, Lothar Lindemann, Aia E Jønch, George Apostol, Mark F Bear, Randall L Carpenter, Jacqueline N Crawley, Aurore Curie, Vincent Des Portes, Farah Hossain,[...]. Nat Rev Drug Discov 2018
18
Altered Neuronal and Circuit Excitability in Fragile X Syndrome.
Anis Contractor, Vitaly A Klyachko, Carlos Portera-Cailliau. Neuron 2015
Anis Contractor, Vitaly A Klyachko, Carlos Portera-Cailliau. Neuron 2015
17
Pharmacogenetic inhibition of eIF4E-dependent Mmp9 mRNA translation reverses fragile X syndrome-like phenotypes.
Christos G Gkogkas, Arkady Khoutorsky, Ruifeng Cao, Seyed Mehdi Jafarnejad, Masha Prager-Khoutorsky, Nikolaos Giannakas, Archontia Kaminari, Apostolia Fragkouli, Karim Nader, Theodore J Price,[...]. Cell Rep 2014
Christos G Gkogkas, Arkady Khoutorsky, Ruifeng Cao, Seyed Mehdi Jafarnejad, Masha Prager-Khoutorsky, Nikolaos Giannakas, Archontia Kaminari, Apostolia Fragkouli, Karim Nader, Theodore J Price,[...]. Cell Rep 2014
17
Dysregulation and restoration of translational homeostasis in fragile X syndrome.
Joel D Richter, Gary J Bassell, Eric Klann. Nat Rev Neurosci 2015
Joel D Richter, Gary J Bassell, Eric Klann. Nat Rev Neurosci 2015
17
The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1.
Weidong Li, Yijun Cui, Steven A Kushner, Robert A M Brown, J David Jentsch, Paul W Frankland, Tyrone D Cannon, Alcino J Silva. Curr Biol 2005
Weidong Li, Yijun Cui, Steven A Kushner, Robert A M Brown, J David Jentsch, Paul W Frankland, Tyrone D Cannon, Alcino J Silva. Curr Biol 2005
16
Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression.
Lingfei Hou, Marcia D Antion, Daoying Hu, Corinne M Spencer, Richard Paylor, Eric Klann. Neuron 2006
Lingfei Hou, Marcia D Antion, Daoying Hu, Corinne M Spencer, Richard Paylor, Eric Klann. Neuron 2006
16
Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome.
Xinglong Wang, Mike Snape, Eric Klann, Jeremy G Stone, Avneet Singh, Robert B Petersen, Rudy J Castellani, Gemma Casadesus, Mark A Smith, Xiongwei Zhu. J Neurochem 2012
Xinglong Wang, Mike Snape, Eric Klann, Jeremy G Stone, Avneet Singh, Robert B Petersen, Rudy J Castellani, Gemma Casadesus, Mark A Smith, Xiongwei Zhu. J Neurochem 2012
30
Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
Christina Gross, Mika Nakamoto, Xiaodi Yao, Chi-Bun Chan, So Y Yim, Keqiang Ye, Stephen T Warren, Gary J Bassell. J Neurosci 2010
Christina Gross, Mika Nakamoto, Xiaodi Yao, Chi-Bun Chan, So Y Yim, Keqiang Ye, Stephen T Warren, Gary J Bassell. J Neurosci 2010
15
The translation of translational control by FMRP: therapeutic targets for FXS.
Jennifer C Darnell, Eric Klann. Nat Neurosci 2013
Jennifer C Darnell, Eric Klann. Nat Neurosci 2013
15
Selective role of the catalytic PI3K subunit p110β in impaired higher order cognition in fragile X syndrome.
Christina Gross, Nisha Raj, Gemma Molinaro, Amanda G Allen, Alonzo J Whyte, Jay R Gibson, Kimberly M Huber, Shannon L Gourley, Gary J Bassell. Cell Rep 2015
Christina Gross, Nisha Raj, Gemma Molinaro, Amanda G Allen, Alonzo J Whyte, Jay R Gibson, Kimberly M Huber, Shannon L Gourley, Gary J Bassell. Cell Rep 2015
27
The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP.
Ilaria Napoli, Valentina Mercaldo, Pietro Pilo Boyl, Boris Eleuteri, Francesca Zalfa, Silvia De Rubeis, Daniele Di Marino, Evita Mohr, Marzia Massimi, Mattia Falconi,[...]. Cell 2008
Ilaria Napoli, Valentina Mercaldo, Pietro Pilo Boyl, Boris Eleuteri, Francesca Zalfa, Silvia De Rubeis, Daniele Di Marino, Evita Mohr, Marzia Massimi, Mattia Falconi,[...]. Cell 2008
15
Open-label add-on treatment trial of minocycline in fragile X syndrome.
Carlo Paribello, Leeping Tao, Anthony Folino, Elizabeth Berry-Kravis, Michael Tranfaglia, Iryna M Ethell, Douglas W Ethell. BMC Neurol 2010
Carlo Paribello, Leeping Tao, Anthony Folino, Elizabeth Berry-Kravis, Michael Tranfaglia, Iryna M Ethell, Douglas W Ethell. BMC Neurol 2010
15
The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome.
Sien Braat, Charlotte D'Hulst, Inge Heulens, Silvia De Rubeis, Edwin Mientjes, David L Nelson, Rob Willemsen, Claudia Bagni, Debby Van Dam, Peter P De Deyn,[...]. Cell Cycle 2015
Sien Braat, Charlotte D'Hulst, Inge Heulens, Silvia De Rubeis, Edwin Mientjes, David L Nelson, Rob Willemsen, Claudia Bagni, Debby Van Dam, Peter P De Deyn,[...]. Cell Cycle 2015
30
Arbaclofen in fragile X syndrome: results of phase 3 trials.
Elizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, Dejan Budimirovic, Walter E Kaufmann, Maryann Cherubini, Peter Zarevics, Karen Walton-Bowen, Paul Wang, Mark F Bear,[...]. J Neurodev Disord 2017
Elizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, Dejan Budimirovic, Walter E Kaufmann, Maryann Cherubini, Peter Zarevics, Karen Walton-Bowen, Paul Wang, Mark F Bear,[...]. J Neurodev Disord 2017
16
High MMP-9 activity levels in fragile X syndrome are lowered by minocycline.
Magdalena Dziembowska, Dalyir I Pretto, Aleksandra Janusz, Leszek Kaczmarek, Mary Jacena Leigh, Nielsen Gabriel, Blythe Durbin-Johnson, Randi J Hagerman, Flora Tassone. Am J Med Genet A 2013
Magdalena Dziembowska, Dalyir I Pretto, Aleksandra Janusz, Leszek Kaczmarek, Mary Jacena Leigh, Nielsen Gabriel, Blythe Durbin-Johnson, Randi J Hagerman, Flora Tassone. Am J Med Genet A 2013
15
Targeting the endocannabinoid system in the treatment of fragile X syndrome.
Arnau Busquets-Garcia, Maria Gomis-González, Thomas Guegan, Carmen Agustín-Pavón, Antoni Pastor, Susana Mato, Alberto Pérez-Samartín, Carlos Matute, Rafael de la Torre, Mara Dierssen,[...]. Nat Med 2013
Arnau Busquets-Garcia, Maria Gomis-González, Thomas Guegan, Carmen Agustín-Pavón, Antoni Pastor, Susana Mato, Alberto Pérez-Samartín, Carlos Matute, Rafael de la Torre, Mara Dierssen,[...]. Nat Med 2013
14
The pathophysiology of fragile X (and what it teaches us about synapses).
Asha L Bhakar, Gül Dölen, Mark F Bear. Annu Rev Neurosci 2012
Asha L Bhakar, Gül Dölen, Mark F Bear. Annu Rev Neurosci 2012
14
Conserved hippocampal cellular pathophysiology but distinct behavioural deficits in a new rat model of FXS.
Sally M Till, Antonis Asiminas, Adam D Jackson, Danai Katsanevaki, Stephanie A Barnes, Emily K Osterweil, Mark F Bear, Sumantra Chattarji, Emma R Wood, David J A Wyllie,[...]. Hum Mol Genet 2015
Sally M Till, Antonis Asiminas, Adam D Jackson, Danai Katsanevaki, Stephanie A Barnes, Emily K Osterweil, Mark F Bear, Sumantra Chattarji, Emma R Wood, David J A Wyllie,[...]. Hum Mol Genet 2015
24
Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome.
V Brown, P Jin, S Ceman, J C Darnell, W T O'Donnell, S A Tenenbaum, X Jin, Y Feng, K D Wilkinson, J D Keene,[...]. Cell 2001
V Brown, P Jin, S Ceman, J C Darnell, W T O'Donnell, S A Tenenbaum, X Jin, Y Feng, K D Wilkinson, J D Keene,[...]. Cell 2001
14
Advances in the treatment of fragile X syndrome.
Randi J Hagerman, Elizabeth Berry-Kravis, Walter E Kaufmann, Michele Y Ono, Nicole Tartaglia, Ave Lachiewicz, Rebecca Kronk, Carol Delahunty, David Hessl, Jeannie Visootsak,[...]. Pediatrics 2009
Randi J Hagerman, Elizabeth Berry-Kravis, Walter E Kaufmann, Michele Y Ono, Nicole Tartaglia, Ave Lachiewicz, Rebecca Kronk, Carol Delahunty, David Hessl, Jeannie Visootsak,[...]. Pediatrics 2009
14
Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome.
Jay R Gibson, Aundrea F Bartley, Seth A Hays, Kimberly M Huber. J Neurophysiol 2008
Jay R Gibson, Aundrea F Bartley, Seth A Hays, Kimberly M Huber. J Neurophysiol 2008
13
FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels.
Pan-Yue Deng, Ziv Rotman, Jay A Blundon, Yongcheol Cho, Jianmin Cui, Valeria Cavalli, Stanislav S Zakharenko, Vitaly A Klyachko. Neuron 2013
Pan-Yue Deng, Ziv Rotman, Jay A Blundon, Yongcheol Cho, Jianmin Cui, Valeria Cavalli, Stanislav S Zakharenko, Vitaly A Klyachko. Neuron 2013
13
Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome.
Jose Luis Olmos-Serrano, Scott M Paluszkiewicz, Brandon S Martin, Walter E Kaufmann, Joshua G Corbin, Molly M Huntsman. J Neurosci 2010
Jose Luis Olmos-Serrano, Scott M Paluszkiewicz, Brandon S Martin, Walter E Kaufmann, Joshua G Corbin, Molly M Huntsman. J Neurosci 2010
13
Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.
Craig A Erickson, Logan K Wink, Balmiki Ray, Maureen C Early, Elizabeth Stiegelmeyer, Lauren Mathieu-Frasier, Vanessa Patrick, Debomoy K Lahiri, Christopher J McDougle. Psychopharmacology (Berl) 2013
Craig A Erickson, Logan K Wink, Balmiki Ray, Maureen C Early, Elizabeth Stiegelmeyer, Lauren Mathieu-Frasier, Vanessa Patrick, Debomoy K Lahiri, Christopher J McDougle. Psychopharmacology (Berl) 2013
19
Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.
Jennifer A Ronesi, Katie A Collins, Seth A Hays, Nien-Pei Tsai, Weirui Guo, Shari G Birnbaum, Jia-Hua Hu, Paul F Worley, Jay R Gibson, Kimberly M Huber. Nat Neurosci 2012
Jennifer A Ronesi, Katie A Collins, Seth A Hays, Nien-Pei Tsai, Weirui Guo, Shari G Birnbaum, Jia-Hua Hu, Paul F Worley, Jay R Gibson, Kimberly M Huber. Nat Neurosci 2012
13
Metformin as targeted treatment in fragile X syndrome.
A B C Dy, F Tassone, M Eldeeb, M J Salcedo-Arellano, N Tartaglia, R Hagerman. Clin Genet 2018
A B C Dy, F Tassone, M Eldeeb, M J Salcedo-Arellano, N Tartaglia, R Hagerman. Clin Genet 2018
32
Lovastatin corrects ERK pathway hyperactivation in fragile X syndrome: potential of platelet's signaling cascades as new outcome measures in clinical trials.
David Pellerin, Artuela Çaku, Mathieu Fradet, Paméla Bouvier, Jean Dubé, François Corbin. Biomarkers 2016
David Pellerin, Artuela Çaku, Mathieu Fradet, Paméla Bouvier, Jean Dubé, François Corbin. Biomarkers 2016
52
Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology.
Tsuyoshi Udagawa, Natalie G Farny, Mira Jakovcevski, Hanoch Kaphzan, Juan Marcos Alarcon, Shobha Anilkumar, Maria Ivshina, Jessica A Hurt, Kentaro Nagaoka, Vijayalaxmi C Nalavadi,[...]. Nat Med 2013
Tsuyoshi Udagawa, Natalie G Farny, Mira Jakovcevski, Hanoch Kaphzan, Juan Marcos Alarcon, Shobha Anilkumar, Maria Ivshina, Jessica A Hurt, Kentaro Nagaoka, Vijayalaxmi C Nalavadi,[...]. Nat Med 2013
14
Absence of expression of the FMR-1 gene in fragile X syndrome.
M Pieretti, F P Zhang, Y H Fu, S T Warren, B A Oostra, C T Caskey, D L Nelson. Cell 1991
M Pieretti, F P Zhang, Y H Fu, S T Warren, B A Oostra, C T Caskey, D L Nelson. Cell 1991
12
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.
Elizabeth Berry-Kravis, Allison Sumis, Crystal Hervey, Michael Nelson, Stephen W Porges, Ning Weng, Ivan Jeanne Weiler, William T Greenough. J Dev Behav Pediatr 2008
Elizabeth Berry-Kravis, Allison Sumis, Crystal Hervey, Michael Nelson, Stephen W Porges, Ning Weng, Ivan Jeanne Weiler, William T Greenough. J Dev Behav Pediatr 2008
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.